The post GOG-3073/ ENGOT-ov72/ APGOT-Ov10/ LACOG-0223/ ROSELLA FDA APPROVAL PODCAST appeared first on GOG.

The post InnovaTV 205 GOG-3024/ENGOT-cx8 Publication Podcast appeared first on GOG.

The post Uterine Cancer Awareness Month 2026 Podcast appeared first on GOG.

The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast:
Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem

★ Support this podcast ★

The post Accrual Culture: Top Points for Site Selection – Timelines appeared first on GOG.

The post Accrual Culture: Top Points for Site Selection – Responsiveness appeared first on GOG.

In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer.

★ Support this podcast ★

The post GOG-3101 | TroFuse-20 Clinical Trial Update appeared first on GOG.

The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major medical meetings throughout the year.  

The GOG Highlight Reel distills practice-changing information disclosed during recent major medical meetings into a two-and-a-half-hour segment. This comprehensive course examines recent clinical trial data in gynecologic malignancies, offering insights on data presentations, ongoing research, and drug approvals shaping the field. It addresses common gynecologic malignancies, aiding physicians in comprehending the evolving treatment landscape, including understanding trials in progress. Participants will receive a synthesis of recent studies and explore key components of clinical trials, gaining essential knowledge for research in these malignancies. Dynamic discussions will focus on emerging approved therapies and investigational agents, with an intent to provide insights into current (as well as future) advancements. Join us for a journey through clinical trials in ovarian, endometrial and cervical cancers, gaining the skills to navigate the latest oncology research and clinical care confidently.

The GOG Foundation, Inc. is grateful for our commercial supporters for Independent Medical Education Support associated with this Symposium: GSK, Merck, AbbVie, AstraZeneca, Corcept Therapeutics, Verastem, Eisai, Natera, Karyopharm Therapeutics, BioNTech

The GOG Foundation, Inc. would also like to thank our sponsors for this symposium: Gilead, Faeth Therapeutics

★ Support this podcast ★

The post The GOG Highlight Reel – January 2026 appeared first on GOG.

The post KEYNOTE-B96 FDA APPROVAL REVIEW appeared first on GOG.

The post Accrual Culture: Top Points for Site Selection – Feasibility appeared first on GOG.

The GOG Partners Leadership presents the “Accrual Culture: An Education Series on How to Build a Successful Clinical Trial Network.” The purpose of this on-demand education series is to share key components for developing successful clinical trials. Our expert leaders will share their knowledge, experience, and best practices to integrate into your clinical trial process.

★ Support this podcast ★

The post Accrual Culture: Top Points for Site Selection – Enrollement appeared first on GOG.